Abstract: Objective To investigate the involvement of transient receptor potential vanilloid receptor 1 (TRPV1) in the facial inflammatory pain in relation to thermal hyperalgesia and cold pain sensation. Methods Facial inflammatory pain model was developed by subcutaneous injection of turpentine oil (TO) into rat facial area. Head withdrawal thermal latency (HWTL) and head withdrawal cold latency (HWCL) were measured once a day for 21 d after TO treatment using thermal and cold measurement apparatus. The immunohistochemical staining, cell-size frequency analysis and the survey of average optical density (OD) value were used to observe the changes of TRPV1 expression in the neurons of the trigeminal ganglion (TG), peripheral nerve fibers in the vibrissal pad, and central projection processes in the trigeminal sensory nuclei caudalis (Vc) on day 3, 5, 7, 14, and 21 after TO injection. Results HWTL and HWCL decreased significantly from day 1 to day 14 after TO injection with the lowest value on day 5 and day 3, respectively, and both recovered on day 21. The number of TRPV1-labeled neurons increased remarkably from day 1 to day 14 with a peak on day 7, and returned back to the normal level on day 21. In control rats, only small and medium-sized TG neurons were immunoreactive (IR) to TRPV1, and the TRPV1-IR terminals were abundant in both the vibrissal pad and the Vc. Within 2 weeks of inflammation, the expression of TRPV1 in small and medium-sized TG neurons increased obviously. Also the TRPV1 stained terminals and fibers appeared more frequent and denser in both the vibrissal pad skin and throughout laminae I and the outer zone of laminae II (IIo) of Vc. Conclusion Facial inflammatory pain could induce hyperalgesia to noxious heat and cold stimuli, and result in increase of the numbers of TRPV1 positive TG neurons and the peripheral and central terminals of TG. These results suggest that the phenotypic changes of TRPV1 expression in small and medium-sized TG neurons and terminals might play an important role in the development and maintenance of TO-induced inflammatory thermal hyperalgesia and cold pain sensation.
Introduction
Transient receptor potential vanilloid receptor 1 (TRPV1), also called vanilloid receptor 1 (VR1), is a nonselective cation channel gated by noxious heat, proton and capsaicin [1, 2] . Under normal state, regarding primary sensory neurons, TRPV1 is expressed in small (TG) neurons, which dominate the skin and cornea with their unmyelinated axons, and project to the brain stem with their central processes [3] . Under peripheral tissue injury and inflammation, TRPV1 expression is largely increased in peripheral terminals [4] . It is thus believed that the level of peripheral TRPV1 is likely an index of peripheral sensitization of thermal nociceptors and is probably responsible for the production and maintenance of hyperalgesia.
TRPV1 is essential for the development of thermal hyperalgesia, as mice lacking this receptor lack thermal hyperalgesia after inflammation [5] . In addition, the upregulation of TRPV1 expression contributes to the development of inflammatory heat hyperalgesia [6] [7] [8] . It has been found that the proportion of unmyelinated axons expressing TRPV1 increases in the inflamed tissues, and that inflammation increases the number of TRPV1-expression primary sensory neurons in the dorsal root ganglia (DRG) [6, 7] . Studies in vitro have shown that substances produced by local inflammation such as ATP [9] , bradykinin (BK) [10] and Lei PEI, et al Pain and TRPV1 expression in rat trigeminal ganglion nerve growth factor (NGF) [11] could increase the capsaicinevoked current in TRPV1 expressed cells. These functional modulations of TRPV1 channels, however, cannot explain why the number of active neurons increases after inflammation. Therefore novel recruitment of TRPV1 expression would be necessary. Other studies have also demonstrated the changes in TRPV1 protein expression in rat hind paw skin, sciatic nerve and DRG on day 2 and day 7 after complete Freund's adjuvant (CFA) injected [4, 8] . Previous reports were focused on the role of TRPV1 during relatively short period (less than or equal to 1 week) after peripheral inflammation. Only a few studies reported the expression of TRPV1 in TG, vibrissal pad and the trigeminal sensory nuclei caudalis (Vc) at different time points during a relative long period of facial inflammatory pain. Therefore, in the present study, by using behavioral survey and immunohistochemical analyses, we attempted to determine whether the hyperlagesia and cold pain sensation induced by inflammation have correlations with the change of TRPV1 expression in the TG neurons with different size as well as in the TG peripheral and central terminals during the full time course of inflammatory nociception.
Materials and methods

Animals
The experiments were carried out on the male adult Sprague-Dawley (SD) rats (150-200 g) purchased from the Experimental Animals Center of Tongji Medical College of Huazhong University of Science and Technology. All animal experiments were approved by the Animal Care Committee of Huazhong University of Science and Technology and complied with the ethical guidelines of the International Association for the Study of Pain (IASP) [12] . SD rats were individually housed in cages with a natural light/dark cycle and had accessed water and food ad lib. Total 24 rats were used for the present experiment, 20 rats were treated with turpentine oil (TO) and persisted experimental observations until day 3, 5, 7, 14, and 21 (n = 4 rats for each time point), respectively, and the left 4 rats were used as control without treatment. Animals were habituated to the pain testing paradigms for 3-5 d before data collection.
Establishment of facial inflammatory pain model
Three days after acclimation to the laboratory environment and measurement of basic pain threshold, 50 L turpentine oil (TO, Shanghai chemical industry, China) solution (TO: paraffinum = 1:1) was subcutaneously injected into the left supraorbital, infraobital and vibrissae skin of the rat under light anesthesia with 10% chloral hydrate by abdominal injection. Typical signs of acute inflammation including edema, redness and heat were most obvious on days 1 to day 3 after injection and lasted for more than 2 weeks. 2.3 Behavioral tests 2.3.1 Thermal hyperalgesia The latency to radiant heat (s) was measured by a radiant heat apparatus (Department of Physiology of the Fourth Military Medical University, China), prior to 0 d and lasted for 3 weeks after TO administration. Rats were allowed to acclimatize them within a (8×10×18) cm 3 transparent plastic membrane sheath. A radiant heat source (i.e. high-intensity projector lamp bulb) was controlled with a timer to switch on and focused on the beard area. Both lamp and timer were halted by a photocell when the head withdrew, and head withdrawal thermal latency (HWTL) was measured at the same time. Five trials with a 10-min intertrial interval were conducted on each rat's beard area. The voltage was adjusted to derive an average baseline thermal threshold of approximately 20 s, and a maximal cut-off of 30 s was employed to prevent tissue damage. Results were expressed as mean ± SEM.
Cold pain sensation
According to the principles of cold plate test [13] and the animal models of cold pain sensation [14] , ice cool water [(0±1) ºC] was taken in a hermetical test-tube. Use the tip of this cold test-tube to lightly touch the facial area of the rats and the head withdrawal cold latency (HWCL) (s) was measured just prior to 0 d and lasted for 3 weeks after TO injection. Five trials with a 10-min intertrial interval were conducted on each rat's beard area. The cut off time was 30 s. Results were expressed as mean ± SEM. 2.4 Immunohistochemical staining On day 3, 5, 7, 14, and 21 after TO injection and pain measurements, rats were deeply anesthetized with 10% chloral hydrate (350 mg/kg, i.p.) and transcardialy perfused with 300 mL of saline followed by 500 mL of 4% paraformaldehyde in 0.1 mol/L phosphate buffer (PB, pH 7.6). After the perfusion, the TG and vibrissal pad of the injecting side and the brainstem were removed, kept in the same fixative for 6 h, and then cryoprotected in 30% sucrose in 0.1 mol/L PB (4 ºC) overnight. The sections (20 m) were cut on a cryostat, collected sequentially in 4 vials (with a minimum separation of 80 m between the sections), and immersed in 0.05 mol/L Tris Buffer Saline (TBS, pH 7.4). Immunohistochemical staining for TRPV1 was performed with avidin-biotin-horse-
